Newsroom

APRIL 27 2021 Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included:$9m debt financing from SVB, and$12m equity investment led by Savitr Capital and other private investors. Led by Ed Furlong, President and Chief Executive Officer, Glytec is an insulin management software company that delivers...

MAY 9 2021 Omar Ford COVID-19 and digital health are two subjects that loomed largely in this year’s Medical Design Excellence Awards (MDEA) Program. The prestigious award program—recognizing cutting-edge achievements in medical product design since 1998— spans 11 categories and celebrates the Best in Show and MD+DI Readers' Choice. (For a complete list of finalists, please click here) With...

APRIL 26 2021 Christine Hall Glytec is developing software that aims to set the standard for insulin dosing and glycemic management in hospitals. On Monday, the company brought in a new round of $21 million in equity and debt financing. More than 34 million Americans today live with diabetes, while 88 million live with prediabetes and over one-third of all patients — regardless of a diabetes...

APRIL 26 2021 Steven Loeb The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don't are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven't invested in computerized protocols to deliver personalized dosing regimens,...

APRIL 26 2021 Steven Loeb The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don't are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven't invested in computerized protocols to deliver personalized dosing regimens, meaning...

APRIL 27 2021 Dennis Dailey Funding from Silicon Valley Bank and Savitr Capital Fuels Growth and Accelerates Innovation to Address Glycemic Management Challenges at Vast Majority of Hospitals Glytec, a provider of insulin management software across the continuum of care, announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding...

APRIL 26, 2021 Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included: $9m debt financing from SVB, and $12m equity investment led by Savitr Capital and other private investors. The company intends to use the funds to invest in research and development around patient safety, provider workflows and...

WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million...

New Enhancements & Integrations for eGlycemic Management System Streamline Provider Workflows and Introduce Additional Guardrails for Safe and Effective Insulin Dosing WALTHAM, MASS. (March 30, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today introduced the latest version of its eGlycemic Management System® (eGMS), including enhancements and...

OCTOBER 30, 2018 Glytec publishes free eBook: Hypoglycemia in the hospital. Why is it costing you millions and what can you do? The popular eBook showcases clinical and financial implications of hypoglycemia, a common occurrence among hospitalized patients that costs the average hospital $1.5 to $5.6 million a year, or more. Waltham, MA — Hypoglycemia in the hospital is common, costly, extremely...